Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis
about
Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activationThe human 64-kDa polyadenylylation factor contains a ribonucleoprotein-type RNA binding domain and unusual auxiliary motifsCharacterization and cloning of the human splicing factor 9G8: a novel 35 kDa factor of the serine/arginine protein familyRXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptorsHIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox stateIn vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factorTat protein induces self-perpetuating permissivity for productive HIV-1 infectionCell-to-Cell Spread of the RNA Interference Response Suppresses Semliki Forest Virus (SFV) Infection of Mosquito Cell Cultures and Cannot Be Antagonized by SFVA novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitroExpression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: both Fos and Jun contact DNA directlyNF-kappa B subunit-specific regulation of the interleukin-8 promoterInterpretation of matrix-assisted laser desorption/ionization postsource decay spectra of charge-derivatized peptides: some examples of tris[(2,4,6-trimethoxyphenyl) phosphonium]-tagged proteolytic digestion products of phosphoenolpyruvate carboxykiRNA transcripts of the human immunodeficiency virus transactivation response element can inhibit action of the viral transactivator.Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat.Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1.Chemically well-defined self-assembled monolayers for cell culture: toward mimicking the natural ECMActivity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1Rotational symmetry in ribonucleotide strand requirements for binding of HIV-1 Tat protein to TAR RNASRY protein enhances transcription of Fos-related antigen 1 promoter constructs.Characterization of two mutations associated with epimerase-deficiency galactosemia, by use of a yeast expression system for human UDP-galactose-4-epimeraseHuman immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesotheliomaExtracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency.Endocytosis and targeting of exogenous HIV-1 Tat protein.The relationship between serum p53 autoantibodies and characteristics of human breast cancer.A Jun-binding protein related to a putative tumor suppressorInhibition of human immunodeficiency virus type 1 Tat-dependent activation of translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires trans-activation response element loop sequencesTAR-independent transactivation of the murine cytomegalovirus major immediate-early promoter by the Tat proteinRelease, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation.Adenovirus E4orf4 protein binds to protein phosphatase 2A, and the complex down regulates E1A-enhanced junB transcription.Definition of the transcriptional activation domain of recombinant 43-kilodalton USF.Function of the human immunodeficiency virus types 1 and 2 Rev proteins is dependent on their ability to interact with a structured region present in env gene mRNA.Critical chemical features in trans-acting-responsive RNA are required for interaction with human immunodeficiency virus type 1 Tat protein.Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative.Genetic regulation of human immunodeficiency virus.Tat and Rev: positive modulators of human immunodeficiency virus gene expression.Identification of the coding region for a second poly(A) polymerase in Escherichia coli.Heterodimer formation and activity in the human enzyme galactose-1-phosphate uridylyltransferaseRapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus.
P2860
Q24293705-1A0EEDD0-11F2-498D-AAEF-15C4FD0F6583Q24301982-DD2A3426-5C93-47CD-84C7-96A95DBC5876Q24312227-B17BE707-0DFC-4BA2-8EC6-F62319F60F40Q24555693-6303228F-E8FB-4B1B-8079-875B0EE95A8AQ24568360-AD42C233-873E-4B69-94C4-CB69790ABB96Q24655901-CCB9D578-0BA5-4202-AC68-BC3FED9D4D8BQ24683211-340FF097-0DBB-4F3B-8D88-9050689D19F9Q27488395-8CD6FFDD-DA2F-472C-AC88-A7E0DC4C120BQ28306373-13823122-9A01-4B74-A12A-DB298BCBBF2BQ28580048-3B6FB853-23E4-4096-9CCF-6EB1079902FDQ28646361-3860C48A-9FA1-4315-9B7C-32FCDCAB8909Q30841677-2F9BC0E3-F971-442A-880B-2873551F1145Q33719689-1A3C8E43-2063-4F62-987B-B252034CBCBCQ33782959-321B0119-980A-4277-90C1-BFE78E6F202DQ33785321-346E6F7E-4D63-4E13-8AD7-92D57BA6F452Q33815010-910C4D93-E276-41C5-A976-971A26F7038CQ34155112-377CF2CB-AA8A-4925-8670-76895FD4C0A6Q34306796-A59FB901-46BC-4645-A764-F8551C8FE0F7Q34961590-C0FD1212-B0EC-4225-B01C-9383E0EDE3B6Q35230357-48D6FDC1-B60E-4AFC-A634-B02076D37732Q35249400-AD11D767-4134-4138-99F0-F4452811F578Q35585108-5F1836A0-FF7F-4927-B6A1-933EA72A4C00Q35796277-62FC9430-73B4-4E8A-AEB4-34446D5864FAQ35832979-AAF123E1-425D-4A7B-9BFB-24FA4368EC86Q35926764-33B0C7DD-4CDC-49CF-B96F-F464E24FD79CQ35979208-55C2E88D-A548-4277-BD1C-0735D011D54CQ36428098-3D1F2F90-9156-475F-847A-BECFF474E62CQ36618678-44552C86-6283-4DEA-BCC9-5BD1983D2CD3Q36639281-3F7C39FD-8CC5-41FE-80CC-719CDEFB7946Q36639380-D312FBC5-ECDF-4F96-A2C7-1A1D933C2980Q36655478-575A5BAE-59DA-4FB9-BB9B-EE647A6693FAQ36705097-70800E6A-276A-42A4-BF53-A570A25588E0Q36783107-98BE4F53-F442-44AF-BF00-9D8DE2CC8861Q36798014-508163BF-1AB3-48A3-B86A-C227948034EFQ36811336-2686806D-C9E8-42A9-A13A-E78D34B50CE0Q37056955-FCA3B6DF-1C33-45C3-94C9-876A7C6AA48CQ37059502-9E8C4FF0-26E9-465D-9B3A-E257B8DBFBFBQ37259941-0FA60D61-DC6B-47DA-A18B-AFCB8B586724Q37492209-E3DACAD9-9571-449B-9850-D2595F39E7E6Q37604177-2BC63BDD-20EE-4A8C-8249-DCACB1D1C96A
P2860
Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis
description
1989 nî lūn-bûn
@nan
1989 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
name
Bioassay for trans-activation ...... vation requires mRNA synthesis
@ast
Bioassay for trans-activation ...... vation requires mRNA synthesis
@en
type
label
Bioassay for trans-activation ...... vation requires mRNA synthesis
@ast
Bioassay for trans-activation ...... vation requires mRNA synthesis
@en
prefLabel
Bioassay for trans-activation ...... vation requires mRNA synthesis
@ast
Bioassay for trans-activation ...... vation requires mRNA synthesis
@en
P2093
P2860
P356
P1476
Bioassay for trans-activation ...... vation requires mRNA synthesis
@en
P2093
P2860
P304
P356
10.1073/PNAS.86.3.821
P407
P577
1989-02-01T00:00:00Z